- Home
- VRDN vs BAK Comparison
VRDN vs BAK Comparison
Compare VRDN & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- BAK
- Stock Information
- Founded
- VRDN 2006
- BAK 1972
- Country
- VRDN United States
- BAK Brazil
- Employees
- VRDN N/A
- BAK N/A
- Industry
- VRDN Medical Specialities
- BAK Major Chemicals
- Sector
- VRDN Health Care
- BAK Industrials
- Exchange
- VRDN Nasdaq
- BAK Nasdaq
- Market Cap
- VRDN 1.5B
- BAK 1.3B
- IPO Year
- VRDN N/A
- BAK N/A
- Fundamental
- Price
- VRDN $18.87
- BAK $3.32
- Analyst Decision
- VRDN Strong Buy
- BAK Buy
- Analyst Count
- VRDN 11
- BAK 2
- Target Price
- VRDN $38.80
- BAK $7.50
- AVG Volume (30 Days)
- VRDN 877.5K
- BAK 803.2K
- Earning Date
- VRDN 11-11-2025
- BAK 11-05-2025
- Dividend Yield
- VRDN N/A
- BAK N/A
- EPS Growth
- VRDN N/A
- BAK N/A
- EPS
- VRDN N/A
- BAK N/A
- Revenue
- VRDN $305,000.00
- BAK $14,266,076,929.00
- Revenue This Year
- VRDN N/A
- BAK $4.10
- Revenue Next Year
- VRDN $35,092.81
- BAK $11.25
- P/E Ratio
- VRDN N/A
- BAK N/A
- Revenue Growth
- VRDN 5.90
- BAK 10.48
- 52 Week Low
- VRDN $9.90
- BAK $2.80
- 52 Week High
- VRDN $27.20
- BAK $7.71
- Technical
- Relative Strength Index (RSI)
- VRDN 52.46
- BAK 51.36
- Support Level
- VRDN $18.12
- BAK $3.28
- Resistance Level
- VRDN $20.51
- BAK $3.61
- Average True Range (ATR)
- VRDN 0.94
- BAK 0.12
- MACD
- VRDN -0.01
- BAK 0.00
- Stochastic Oscillator
- VRDN 34.66
- BAK 34.04
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.